Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Zomedica Corp. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ZOM
NYSE American
3840
www.zomedica.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Zomedica Corp.
Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis
- Feb 6th, 2025 11:30 am
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
- Jan 7th, 2025 11:30 am
Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone
- Dec 23rd, 2024 11:30 am
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer
- Dec 19th, 2024 11:30 am
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024
- Nov 27th, 2024 11:30 am
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform
- Nov 14th, 2024 11:30 am
Noble Capital Markets Initiates Equity Research Coverage on Zomedica
- Nov 12th, 2024 11:30 am
Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...
- Nov 8th, 2024 7:02 pm
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024
- Nov 8th, 2024 11:30 am
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
- Nov 7th, 2024 9:25 pm
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform
- Oct 24th, 2024 10:30 am
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET
- Oct 23rd, 2024 11:20 pm
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference
- Oct 15th, 2024 10:30 am
Zomedica Corp (ZOM) Q2 2024 Earnings Call Highlights: Diagnostics Surge Amid Revenue Challenges
- Oct 9th, 2024 10:24 pm
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe
- Oct 3rd, 2024 10:30 am
Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota
- Sep 11th, 2024 10:30 am
Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities
- Sep 5th, 2024 10:30 am
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product
- Aug 29th, 2024 10:30 am
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring System
- Aug 22nd, 2024 10:30 am
Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary Conference
- Aug 20th, 2024 10:30 am
Scroll